Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Service Types
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Therapeutic Area
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on End-Users
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
North America clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Europe clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Asia Pacific clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Latin America clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Middle East & Africa clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Competitive Landscape
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trial Imaging Services Market Snapshot
Chapter 4. Global Clinical Trial Imaging Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Types, Estimates & Trend Analysis
5.1. By Service Types, & Market Share, 2019 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Service Types:
5.2.1. Clinical Trial Design & Consultation Services
5.2.2. Reading & Analytical Services
5.2.3. Operational Imaging Services
5.2.4. Project & Data Management Services
5.2.5. Other Service Types
Chapter 6. Market Segmentation 1: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2019 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Therapeutic Area:
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Endocrinology
6.2.4. Cardiology
6.2.5. Gastroenterology
6.2.6. Other Therapeutic Area
Chapter 7. Market Segmentation 1: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2019 & 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By End-Users:
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Medical Device Manufacturers
7.2.3. Academic & Government Research Institutes
Chapter 8. Clinical Trial Imaging Services Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By Service Types, 2019 - 2030
8.1.2. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2019 - 2030
8.1.3. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By End-Users, 2019 - 2030
8.1.4. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts by country, 2019 - 2030
8.2. Europe
8.2.1. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, 2019 - 2030
8.2.2. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, 2019 - 2030
8.2.3. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, 2019 - 2030
8.2.4. Europe Clinical Trial Imaging Services Market revenue (US$ Million) by country, 2019 - 2030
8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, 2019 - 2030
8.3.2. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, 2019 - 2030
8.3.3. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, 2019 - 2030
8.3.4. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) by country, 2019 - 2030
8.4. Latin America
8.4.1. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, (US$ Million)
8.4.2. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million)
8.4.3. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, (US$ Million)
8.5.2. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million)
8.5.3. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Bioclinica Inc.
9.2.2. Biospective Inc.
9.2.3. Calyx
9.2.4. Ert Clinical
9.2.5. Icon Plc.
9.2.6. Ixico Plc
9.2.7. Intrinsic Imaging, Llc
9.2.8. Imaging Endpoints
9.2.9. Micron, Inc.
9.2.10. Median Technologies
9.2.11. Medpace, Inc.
9.2.12. Pharmtrace
9.2.13. Proscan Imaging
9.2.14. Other Prominent Player
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.